Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of Botulinum Toxin Type A for treating glabellar lines has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Glabellar Frown Lines | Phase 2 | Status: COMPLETED | Results posted: 2024-02-22